Efficacy of immune checkpoint inhibitor therapy in patients with pulmonary sarcomatoid carcinoma in clinical practice

OBJECTIVE: Studies have suggested the potential efficacy of immune checkpoint inhibitors (ICIs) for pulmonary sarcomatoid carcinoma. This multicenter observational study was conducted to evaluate the efficacy of systemic ICI therapy and chemoradiation followed by durvalumab therapy for pulmonary sar...

Descripción completa

Detalles Bibliográficos
Autores principales: Inomata, Minehiko, Tsuda, Takeshi, Ichikawa, Tomomi, Matsumoto, Masahiro, Mizushima, Isami, Azechi, Kenji, Takata, Naoki, Murayama, Nozomu, Hayashi, Kana, Hirai, Takahiro, Seto, Zenta, Tokui, Kotaro, Masaki, Yasuaki, Taka, Chihiro, Okazawa, Seisuke, Kambara, Kenta, Imanishi, Shingo, Taniguchi, Hirokazu, Miwa, Toshiro, Hayashi, Ryuji, Matsui, Shoko, Tobe, Kazuyuki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons Australia, Ltd 2023
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10260484/
https://www.ncbi.nlm.nih.gov/pubmed/37101081
http://dx.doi.org/10.1111/1759-7714.14907

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10260484/
https://www.ncbi.nlm.nih.gov/pubmed/37101081
http://dx.doi.org/10.1111/1759-7714.14907

Ejemplares similares